iPS 细胞是否会增强脐带血细胞治疗的适用性和存储？
Will iPS cells enhance therapeutic applicability of cord blood cells and banking?
机构信息
Department of Microbiology and Immunology, Indiana University School of Medicine, Indianapolis, IN 46202, USA.
出版信息
Cell Stem Cell. 2010 Jan 8;6(1):21-4. doi: 10.1016/j.stem.2009.12.008.
PMID:20074533
Abstract
The exciting development of induced pluripotent stem cells (iPSCs), and the discovery that iPSCs can be derived from cord blood (CB), combined with the presence of nonhematopoietic stem and progenitor cells in CB may lead to enhanced therapeutic applicability of this cell source and induce increased CB banking.
摘要
诱导多能干细胞（iPSC）的令人兴奋的发展，以及发现 iPSC 可以从脐带血（CB）中获得，加上 CB 中存在非造血干细胞和祖细胞，这可能导致提高这种细胞来源的治疗适用性，并促使更多的 CB 存储。
Zotero 插件